Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Patients with Idiopathic Pulmonary Nontuberculous Mycobacterial Disease Have Normal Th1/Th2 Cytokine Responses but Diminished Th17 Cytokine and Enhanced Granulocyte-Macrophage Colony-Stimulating Factor Production.

Wu UI, Olivier KN, Kuhns DB, Fink DL, Sampaio EP, Zelazny AM, Shallom SJ, Marciano BE, Lionakis MS, Holland SM.

Open Forum Infect Dis. 2019 Nov 28;6(12):ofz484. doi: 10.1093/ofid/ofz484. eCollection 2019 Dec.

2.

STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels With Normal Dephosphorylation.

Zimmerman O, Olbrich P, Freeman AF, Rosen LB, Uzel G, Zerbe CS, Rosenzweig SD, Kuehn HS, Holmes KL, Stephany D, Ding L, Sampaio EP, Hsu AP, Holland SM.

Front Immunol. 2019 Jul 10;10:1433. doi: 10.3389/fimmu.2019.01433. eCollection 2019.

3.

Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.

Mendes MA, de Carvalho DS, Amadeu TP, Silva BJA, Prata RBDS, da Silva CO, Ferreira H, Hacker MA, Nery JAC, Pinheiro RO, Sampaio EP, Sarno EN, Schmitz V.

J Infect Dis. 2017 Dec 19;216(12):1635-1643. doi: 10.1093/infdis/jix267.

PMID:
29272525
4.

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

Zimmerman O, Rösler B, Zerbe CS, Rosen LB, Hsu AP, Uzel G, Freeman AF, Sampaio EP, Rosenzweig SD, Kuehn HS, Kim T, Brooks KM, Kumar P, Wang X, Netea MG, van de Veerdonk FL, Holland SM.

Open Forum Infect Dis. 2017 Sep 22;4(4):ofx202. doi: 10.1093/ofid/ofx202. eCollection 2017 Fall.

5.

Transcriptional Response of Respiratory Epithelium to Nontuberculous Mycobacteria.

Matsuyama M, Martins AJ, Shallom S, Kamenyeva O, Kashyap A, Sampaio EP, Kabat J, Olivier KN, Zelazny AM, Tsang JS, Holland SM.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):241-252. doi: 10.1165/rcmb.2017-0218OC.

6.

Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function.

Sampaio EP, Ding L, Rose SR, Cruz P, Hsu AP, Kashyap A, Rosen LB, Smelkinson M, Tavella TA, Ferre EMN, Wierman MK, Zerbe CS, Lionakis MS, Holland SM.

J Allergy Clin Immunol. 2018 May;141(5):1844-1853.e2. doi: 10.1016/j.jaci.2017.07.027. Epub 2017 Aug 30.

7.

Distinct mutations at the same positions of STAT3 cause either loss or gain of function.

Chandrasekaran P, Zimmerman O, Paulson M, Sampaio EP, Freeman AF, Sowerwine KJ, Hurt D, Alcántara-Montiel JC, Hsu AP, Holland SM.

J Allergy Clin Immunol. 2016 Oct;138(4):1222-1224.e2. doi: 10.1016/j.jaci.2016.05.007. Epub 2016 May 24. No abstract available.

8.

Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature.

Zerbe CS, Marciano BE, Katial RK, Santos CB, Adamo N, Hsu AP, Hanks ME, Darnell DN, Quezado MM, Frein C, Barnhart LA, Anderson VL, Uzel G, Freeman AF, Lisco A, Nath A, Major EO, Sampaio EP, Holland SM.

Clin Infect Dis. 2016 Apr 15;62(8):986-94. doi: 10.1093/cid/civ1220. Epub 2016 Jan 6. Review.

9.

Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates.

Park IK, Hsu AP, Tettelin H, Shallom SJ, Drake SK, Ding L, Wu UI, Adamo N, Prevots DR, Olivier KN, Holland SM, Sampaio EP, Zelazny AM.

J Clin Microbiol. 2015 Nov;53(11):3438-47. doi: 10.1128/JCM.02015-15. Epub 2015 Aug 19.

10.

New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.

Shallom SJ, Moura NS, Olivier KN, Sampaio EP, Holland SM, Zelazny AM.

J Clin Microbiol. 2015 Nov;53(11):3430-7. doi: 10.1128/JCM.01714-15. Epub 2015 Aug 12.

11.

Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

Andrade BB, Pavan Kumar N, Amaral EP, Riteau N, Mayer-Barber KD, Tosh KW, Maier N, Conceição EL, Kubler A, Sridhar R, Banurekha VV, Jawahar MS, Barbosa T, Manganiello VC, Moss J, Fontana JR, Marciano BE, Sampaio EP, Olivier KN, Holland SM, Jackson SH, Moayeri M, Leppla S, Sereti I, Barber DL, Nutman TB, Babu S, Sher A.

J Immunol. 2015 Sep 15;195(6):2763-73. doi: 10.4049/jimmunol.1500942. Epub 2015 Aug 12.

12.

Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells.

Wan CK, Andraski AB, Spolski R, Li P, Kazemian M, Oh J, Samsel L, Swanson PA 2nd, McGavern DB, Sampaio EP, Freeman AF, Milner JD, Holland SM, Leonard WJ.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9394-9. doi: 10.1073/pnas.1511711112. Epub 2015 Jul 13.

13.

Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition.

Andrade PR, Pinheiro RO, Sales AM, Illarramendi X, Barbosa MG, Moraes MO, Jardim MR, Nery JA, Sampaio EP, Sarno EN.

Expert Rev Clin Immunol. 2015 Mar;11(3):391-407. doi: 10.1586/1744666X.2015.1012501. Epub 2015 Feb 10. Review.

PMID:
25666357
14.

Effect of apoptotic cell recognition on macrophage polarization and mycobacterial persistence.

de Oliveira Fulco T, Andrade PR, de Mattos Barbosa MG, Pinto TG, Ferreira PF, Ferreira H, da Costa Nery JA, Real SC, Borges VM, Moraes MO, Sarno EN, Sampaio EP, Pinheiro RO.

Infect Immun. 2014 Sep;82(9):3968-78. doi: 10.1128/IAI.02194-14. Epub 2014 Jul 14.

15.

Gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation-related primary immunodeficiency is associated with disseminated mucormycosis.

Kumar N, Hanks ME, Chandrasekaran P, Davis BC, Hsu AP, Van Wagoner NJ, Merlin JS, Spalding C, La Hoz RM, Holland SM, Zerbe CS, Sampaio EP.

J Allergy Clin Immunol. 2014 Jul;134(1):236-9. doi: 10.1016/j.jaci.2014.02.037. Epub 2014 Apr 4. No abstract available.

16.

High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks.

Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VC, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM.

Emerg Infect Dis. 2014 Mar;20(3):364-71. doi: 10.3201/eid2003.131106.

17.

Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Siegelman JR, Shallom S, Park IK, Sampaio EP, Zelazny AM, Holland SM, Prevots DR.

Ann Am Thorac Soc. 2014 Jan;11(1):30-5. doi: 10.1513/AnnalsATS.201307-231OC.

18.

Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7.

Varga JJ, Losada L, Zelazny AM, Kim M, McCorrison J, Brinkac L, Sampaio EP, Greenberg DE, Singh I, Heiner C, Ashby M, Nierman WC, Holland SM, Goldberg JB.

Genome Announc. 2013 Oct 17;1(5). pii: e00841-13. doi: 10.1128/genomeA.00841-13.

19.

Increased prevalence of the alpha-1-antitrypsin (A1AT) deficiency-related S gene in patients infected with human immunodeficiency virus type 1.

Ferreira TC, Sampaio EP, Argañaraz GA, Gondim MV, Shapiro L, Argañaraz ER.

J Med Virol. 2014 Jan;86(1):23-9. doi: 10.1002/jmv.23759. Epub 2013 Oct 12.

PMID:
24122823
20.

New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance.

Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM.

J Clin Microbiol. 2013 Sep;51(9):2943-9. doi: 10.1128/JCM.01132-13. Epub 2013 Jun 26.

21.

Adaptability and persistence of the emerging pathogen Bordetella petrii.

Zelazny AM, Ding L, Goldberg JB, Mijares LA, Conlan S, Conville PS, Stock F, Ballentine SJ, Olivier KN, Sampaio EP, Murray PR, Holland SM.

PLoS One. 2013 Jun 4;8(6):e65102. doi: 10.1371/journal.pone.0065102. Print 2013.

22.

Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011.

de Mello KG, Mello FC, Borga L, Rolla V, Duarte RS, Sampaio EP, Holland SM, Prevots DR, Dalcolmo MP.

Emerg Infect Dis. 2013 Mar;19(3):393-9. doi: http://dx.doi.org/10.3201/eid/1903.120735.

23.

Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.

Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, Chandrasekaran P, Rosen LB, Carvalho DS, Ding L, Vinh DC, Browne SK, Datta S, Milner JD, Kuhns DB, Long Priel DA, Sadat MA, Shiloh M, De Marco B, Alvares M, Gillman JW, Ramarathnam V, de la Morena M, Bezrodnik L, Moreira I, Uzel G, Johnson D, Spalding C, Zerbe CS, Wiley H, Greenberg DE, Hoover SE, Rosenzweig SD, Galgiani JN, Holland SM.

J Allergy Clin Immunol. 2013 Jun;131(6):1624-34. doi: 10.1016/j.jaci.2013.01.052. Epub 2013 Mar 28.

24.

Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.

Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, Noel RJ, Verbsky JW, Freeman AF, Janssen E, Bonilla FA, Pechacek J, Chandrasekaran P, Browne SK, Agharahimi A, Gharib AM, Mannurita SC, Yim JJ, Gambineri E, Torgerson T, Tran DQ, Milner JD, Holland SM.

J Allergy Clin Immunol. 2013 Jun;131(6):1611-23. doi: 10.1016/j.jaci.2012.11.054. Epub 2013 Mar 25.

25.

Interferon alpha treatment of patients with impaired interferon gamma signaling.

Bax HI, Freeman AF, Ding L, Hsu AP, Marciano B, Kristosturyan E, Jancel T, Spalding C, Pechacek J, Olivier KN, Barnhart LA, Boris L, Frein C, Claypool RJ, Anderson V, Zerbe CS, Holland SM, Sampaio EP.

J Clin Immunol. 2013 Jul;33(5):991-1001. doi: 10.1007/s10875-013-9882-5. Epub 2013 Mar 20.

26.

Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Pinheiro RO, de Oliveira EB, Dos Santos G, Sperandio da Silva GM, de Andrade Silva BJ, Teles RM, Milagres A, Sarno EN, Dalcolmo MP, Sampaio EP.

Clin Exp Immunol. 2013 Feb;171(2):210-9. doi: 10.1111/cei.12007.

27.

Draft genome sequence determination for cystic fibrosis and chronic granulomatous disease Burkholderia multivorans isolates.

Varga JJ, Losada L, Zelazny AM, Brinkac L, Harkins D, Radune D, Hostetler J, Sampaio EP, Ronning CM, Nierman WC, Greenberg DE, Holland SM, Goldberg JB.

J Bacteriol. 2012 Nov;194(22):6356-7. doi: 10.1128/JB.01306-12.

28.

Genomic insights into the emerging human pathogen Mycobacterium massiliense.

Tettelin H, Sampaio EP, Daugherty SC, Hine E, Riley DR, Sadzewicz L, Sengamalay N, Shefchek K, Su Q, Tallon LJ, Conville P, Olivier KN, Holland SM, Fraser CM, Zelazny AM.

J Bacteriol. 2012 Oct;194(19):5450. doi: 10.1128/JB.01200-12.

29.

Adult-onset immunodeficiency in Thailand and Taiwan.

Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM.

N Engl J Med. 2012 Aug 23;367(8):725-34. doi: 10.1056/NEJMoa1111160.

30.

Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.

Düppre NC, Camacho LA, Sales AM, Illarramendi X, Nery JA, Sampaio EP, Sarno EN, Bührer-Sékula S.

PLoS Negl Trop Dis. 2012;6(6):e1711. doi: 10.1371/journal.pntd.0001711. Epub 2012 Jun 19.

31.

A framework to identify gene expression profiles in a model of inflammation induced by lipopolysaccharide after treatment with thalidomide.

Paiva RT, Saliba AM, Fulco TO, Sales Jde S, de Carvalho DS, Sampaio EP, Lopes UG, Sarno EN, Nobre FF.

BMC Res Notes. 2012 Jun 13;5:292. doi: 10.1186/1756-0500-5-292.

32.

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients.

Azevedo ZM, Moore DB, Lima FC, Cardoso CC, Bougleux R, Matos GI, Luz RA, Xavier-Elsas P, Sampaio EP, Gaspar-Elsas MI, Moraes MO.

Hum Immunol. 2012 Jun;73(6):661-7. doi: 10.1016/j.humimm.2012.03.007. Epub 2012 Apr 13.

PMID:
22507624
33.

A novel STAT1 mutation associated with disseminated mycobacterial disease.

Sampaio EP, Bax HI, Hsu AP, Kristosturyan E, Pechacek J, Chandrasekaran P, Paulson ML, Dias DL, Spalding C, Uzel G, Ding L, McFarland E, Holland SM.

J Clin Immunol. 2012 Aug;32(4):681-689. doi: 10.1007/s10875-012-9659-2. Epub 2012 Feb 29.

34.

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, Pancholi MJ, Yang LM, Priel DL, Uzel G, Freeman AF, Hayes CE, Baxter R, Cohen SH, Holland SM.

Blood. 2012 Apr 26;119(17):3933-9. doi: 10.1182/blood-2011-12-395707. Epub 2012 Mar 8.

35.

Thalidomide modulates Mycobacterium leprae-induced NF-κB pathway and lower cytokine response.

Hernandez Mde O, Fulco Tde O, Pinheiro RO, Pereira Rde M, Redner P, Sarno EN, Lopes UG, Sampaio EP.

Eur J Pharmacol. 2011 Nov 16;670(1):272-9. doi: 10.1016/j.ejphar.2011.08.046. Epub 2011 Sep 14.

36.

TNF -308G>A single nucleotide polymorphism is associated with leprosy among Brazilians: a genetic epidemiology assessment, meta-analysis, and functional study.

Cardoso CC, Pereira AC, Brito-de-Souza VN, Duraes SM, Ribeiro-Alves M, Nery JA, Francio ÂS, Vanderborght PR, Parelli FP, Alter A, Salgado JL, Sampaio EP, Santos AR, Oliveira ML, Sarno EN, Schurr E, Mira MT, Pacheco AG, Moraes MO.

J Infect Dis. 2011 Oct 15;204(8):1256-63. doi: 10.1093/infdis/jir521.

PMID:
21917899
37.

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM.

Blood. 2011 Sep 8;118(10):2653-5. doi: 10.1182/blood-2011-05-356352. Epub 2011 Jun 13.

38.

The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

de Souza Sales J, Lara FA, Amadeu TP, de Oliveira Fulco T, da Costa Nery JA, Sampaio EP, Pinheiro RO, Sarno EN.

Clin Exp Immunol. 2011 Aug;165(2):251-63. doi: 10.1111/j.1365-2249.2011.04412.x. Epub 2011 May 18.

39.

Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Pinheiro RO, de Souza Salles J, Sarno EN, Sampaio EP.

Future Microbiol. 2011 Feb;6(2):217-30. doi: 10.2217/fmb.10.173. Review.

40.

Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia.

Burbelo PD, Browne SK, Sampaio EP, Giaccone G, Zaman R, Kristosturyan E, Rajan A, Ding L, Ching KH, Berman A, Oliveira JB, Hsu AP, Klimavicz CM, Iadarola MJ, Holland SM.

Blood. 2010 Dec 2;116(23):4848-58. doi: 10.1182/blood-2010-05-286161. Epub 2010 Aug 17.

41.

Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, Spalding C, Hughes S, Pittaluga S, Raffeld M, Sorbara LR, Elloumi HZ, Kuhns DB, Turner ML, Cowen EW, Fink D, Long-Priel D, Hsu AP, Ding L, Paulson ML, Whitney AR, Sampaio EP, Frucht DM, DeLeo FR, Holland SM.

Blood. 2010 Feb 25;115(8):1519-29. doi: 10.1182/blood-2009-03-208629. Epub 2009 Dec 29.

42.

High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.

Teles RM, Teles RB, Amadeu TP, Moura DF, Mendonça-Lima L, Ferreira H, Santos IM, Nery JA, Sarno EN, Sampaio EP.

Infect Immun. 2010 Mar;78(3):1012-21. doi: 10.1128/IAI.00896-09. Epub 2009 Dec 14.

43.

Ulnar neuropathy as a first sign of HIV infection: a diagnostic challenge for leprosy endemic countries.

Jardim MR, Vital R, Illarramendi X, Antunes SL, Nery JA, Sales AM, Moraes MO, Martinez AN, Sampaio EP, Menezes JA, Gripp CB, Morgado MG, Sarno EN.

Arq Neuropsiquiatr. 2009 Sep;67(3A):726-9. No abstract available.

44.

The potential role of magnetic resonance imaging in patients with Hansen's neuropathy of the feet: a preliminary communication.

Slim FJ, Illarramendi X, Maas M, Sampaio EP, Nery JA, Sarno EN, Faber WR.

Int J Low Extrem Wounds. 2009 Sep;8(3):169-73. doi: 10.1177/1534734609345142.

PMID:
19703955
45.

Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease.

Zelazny AM, Ding L, Elloumi HZ, Brinster LR, Benedetti F, Czapiga M, Ulrich RL, Ballentine SJ, Goldberg JB, Sampaio EP, Holland SM.

Infect Immun. 2009 Oct;77(10):4337-44. doi: 10.1128/IAI.00259-09. Epub 2009 Jul 27.

46.

Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ Jr, Olivier KN, Holland SM, Sampaio EP.

J Clin Microbiol. 2009 Jul;47(7):1985-95. doi: 10.1128/JCM.01688-08. Epub 2009 May 6.

47.

The additional benefit of the ML Flow test to classify leprosy patients.

Bührer-Sékula S, Illarramendi X, Teles RB, Penna ML, Nery JA, Sales AM, Oskam L, Sampaio EP, Sarno EN.

Acta Trop. 2009 Aug;111(2):172-6. doi: 10.1016/j.actatropica.2009.04.009. Epub 2009 Apr 23.

PMID:
19393609
48.

HIV-M. leprae interaction: can HAART modify the course of leprosy?

Sarno EN, Illarramendi X, Nery JA, Sales AM, Gutierrez-Galhardo MC, Penna ML, Sampaio EP, Kaplan G.

Public Health Rep. 2008 Mar-Apr;123(2):206-12.

49.

Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells.

Sampaio EP, Elloumi HZ, Zelazny A, Ding L, Paulson ML, Sher A, Bafica AL, Shea YR, Holland SM.

Am J Respir Cell Mol Biol. 2008 Oct;39(4):431-9. doi: 10.1165/rcmb.2007-0413OC. Epub 2008 Apr 25.

50.

Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH.

Clin Vaccine Immunol. 2008 Mar;15(3):522-33. doi: 10.1128/CVI.00432-07. Epub 2008 Jan 16.

Supplemental Content

Loading ...
Support Center